FDA Response Letter Takes over $100M from Dynavax Value
Dynavax Technologies Corp. (NASDAQ: DVAX) was a small cap stock even before today's news, but a complete response letter from U.S. Food and Drug Administration (FDA) has taken more than ...Read Full Story »









